Cytokinetics, Incorporated Cytokinetics, Incorporated

Cytokinetics, Incorporated

CYTK

Classement en actions #2262
Cytokinetics, Incorporated, a biopharmaceutical company, focuses on... Cytokinetics, Incorporated, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel muscle activators and muscle inhibitors as potential treatments for debilitating diseases in the United States. The company markets MYQORZO, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of symptomatic oHCM. It also develops Aficamten, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of HCM; and omecamtiv mecarbil, a potential treatment across the continuum of care in heart failure with severely reduced ejection fraction. In addition, the company is involved in developing and Ulacamten, a novel, selective, oral, and small molecule cardiac myosin inhibitor designed to reduce the hypercontractility associated with heart failure with preserved ejection fraction in Phase 1 clinical trials; and CK-089, a fast skeletal muscle troponin activator in Phase 1 clinical trials. Cytokinetics, Incorporated was incorporated in 1997 and is headquartered in South San Francisco, California.
Prix de l'action
$64.11
Dernière synchronisation: 2026-10-20
Capitalisation boursière
$8.91B
Changement (1 jour)
2.34%
Changement (1 an)
10.96%
Pays
US
Échange Cytokinetics, Incorporated (CYTK)

Catégorie

Healthcare
Historique des divisions d’actions pour Cytokinetics, Incorporated (CYTK)
L’action Cytokinetics, Incorporated (symbole : CYTK) a subi un total de 1 divisions.
La division la plus récente a eu lieu le Jun 25, 2013.
Une action CYTK achetée avant le Jun 25, 2013 équivaudrait aujourd’hui à 0.16666666666667 actions CYTK.
Liste des divisions d’actions
Année Division Multiplicateur Multiplicateur cumulatif
2013-06-25 1:6 x0.16666666666667 x0.16666666666667
Divisions d’actions d’entreprises similaires ou concurrentes
Entreprise Nombre de divisions d’actions Multiplicateur cumulatif Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 0 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 1 x3
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 0 -
CH
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL